Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Brilinta
Brilinta Image

Brilinta

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Brilinta?

Brilinta, also known by its generic name ticagrelor, is a medication classified as an antiplatelet drug. It is prescribed for adults who have suffered a heart attack, or who have a condition called acute coronary syndrome (ACS). This medication works by preventing blood platelets from sticking together and forming clots. By doing so, it reduces the risk of another heart attack or stroke in individuals who have already experienced such events. It is often prescribed in combination with low-dose aspirin. Brilinta is usually taken orally and is available in tablet form. The recommended dosage and duration of treatment may vary depending on individual medical history and condition. It is important to follow the prescribed dosage and continue taking the medication as directed, unless instructed otherwise by a healthcare provider. As with any medication, Brilinta may have potential side effects. The most common side effects reported include bleeding, shortness of breath, headache, dizziness, and nausea. It is crucial to inform a healthcare professional about any other medications, supplements, or medical conditions before starting Brilinta, as certain interactions may occur. If you experience any concerning or persistent side effects while taking Brilinta, it is important to contact your healthcare provider promptly. They will be able to evaluate your symptoms and determine the appropriate course of action. Keep in mind that Brilinta is a prescription medication, and it is essential to follow the guidance of a healthcare professional when taking it. They will monitor your progress and ensure that the benefits of the medication outweigh any potential risks.

How to use Brilinta?

To use Brilinta (ticagrelor) effectively, follow these guidelines: 1. Take the medication exactly as prescribed by your doctor. It is usually taken orally, twice a day, with or without food. Follow the dosage and timing instructions provided. 2. Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet, as it may affect the drug's effectiveness. 3. It is important to continue taking Brilinta for the prescribed duration, even if you start feeling well. Stopping the medication abruptly can increase your risk of developing blood clots or other complications. 4. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses to make up for a missed one. 5. Inform your doctor about all the medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. Some medications may interact with Brilinta, affecting its effectiveness or increasing the risk of side effects. 6. Do not discontinue Brilinta without consulting your doctor. Suddenly stopping this medication may increase the risk of blood clots or other serious cardiovascular problems. 7. While taking Brilinta, it is important to report any unusual bleeding, such as nosebleeds, bleeding gums, prolonged bleeding, or blood in urine or stool, to your doctor. This medication affects your blood's clotting ability, so it is important to monitor for any signs of abnormal bleeding. 8. Inform your healthcare provider of any upcoming surgeries or dental procedures, as Brilinta may need to be temporarily stopped before these procedures to reduce the risk of excessive bleeding. Remember, only take Brilinta as prescribed by your doctor and follow any additional instructions they provide. If you have any concerns or questions about the medication, reach out to your healthcare provider for further guidance.

There are several warnings associated with the use of Brilinta (ticagrelor). It is essential to be aware of these warnings before starting this medication. One significant warning is the risk of bleeding. Brilinta works by inhibiting platelets from aggregating, which can increase the risk of bleeding. It's important to promptly seek medical attention if any unusual bleeding or bruising occurs while taking this medication. Another warning is related to the use of Brilinta in patients with a history of intracranial hemorrhage or bleeding disorders. These patients may have an increased risk of bleeding complications while taking this medication. A thorough evaluation of the risks and benefits should be conducted before prescribing Brilinta for such patients. Additionally, Brilinta should be used with caution in individuals who have a history of asthma or chronic obstructive pulmonary disease (COPD). This is because Brilinta can cause shortness of breath and worsen breathing problems in some patients. If any breathing difficulties occur while taking Brilinta, it's important to seek medical attention promptly. It's crucial to inform healthcare providers about all medications, including over-the-counter drugs and supplements, before starting Brilinta. Some medications, such as other antiplatelet drugs or blood thinners, may increase the risk of bleeding when used in combination with Brilinta. As with any medication, individuals taking Brilinta should be aware of potential allergic reactions. If symptoms such as rash, itching, swelling, dizziness, or difficulty breathing occur, immediate medical attention should be sought. It's important to remember that these warnings are not exhaustive, and it's crucial to follow the guidance and instructions provided by your healthcare provider when taking Brilinta.

Before taking Brilinta (ticagrelor), it is important to be aware of certain warnings and precautions associated with this medication. Here are some key points to consider: 1. Bleeding Risk: Brilinta can increase the risk of bleeding, including serious and potentially life-threatening bleeding events. It is crucial to inform your healthcare provider about any history of bleeding disorders or if you are taking other medications that can increase bleeding risk, such as blood thinners. 2. Aspirin Use: Brilinta is usually prescribed in combination with low-dose aspirin. It is essential to follow your doctor's instructions regarding the use of aspirin, as taking it in higher doses can increase the risk of bleeding. 3. Surgery and Dental Procedures: If you are scheduled to undergo surgery or any dental procedures, it is vital to inform your healthcare provider about your Brilinta use. They may recommend temporarily stopping the medication to minimize the risk of excessive bleeding during the procedure. 4. Allergic Reactions: Allergic reactions to Brilinta are rare but possible. Seek immediate medical attention if you experience symptoms like rash, itching, swelling, dizziness, or difficulty breathing. 5. Liver and Kidney Function: Inform your doctor if you have a history of liver or kidney problems, as adjustments to the Brilinta dosage may be necessary. 6. Drug Interactions: Brilinta can interact with other medications, potentially affecting their effectiveness or increasing the risk of side effects. It is essential to provide your healthcare provider with a complete list of all medications, supplements, or herbal products you are currently taking. 7. Pregnancy and Breastfeeding: The safety of Brilinta during pregnancy and breastfeeding has not been fully established. Discuss the risks and benefits with your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Remember, it is important to always follow your healthcare provider's instructions and consult with them if you have any concerns or questions about taking Brilinta.

Brilinta (ticagrelor) is a medication commonly prescribed as an antiplatelet drug to lower the risk of heart attack, stroke, and other cardiovascular problems. While it is effective for its intended purpose, it can also cause some side effects. Common side effects of Brilinta include: 1. Bleeding: This can manifest as nosebleeds, bruising, prolonged bleeding from cuts, or blood in stools or urine. It is important to promptly report any unexplained bleeding to your doctor. 2. Shortness of breath: Some individuals may experience difficulty breathing or worsening of existing breathing problems. 3. Headache: Headaches are one of the commonly reported side effects of Brilinta. 4. Dizziness: Feeling lightheaded or dizzy can occur as a result of taking this medication. 5. Nausea: Some individuals may experience feelings of nausea or an upset stomach. 6. Diarrhea: Brilinta can cause loose stools or diarrhea in some people. 7. Gastrointestinal discomfort: This may include symptoms like stomach pain, indigestion, or heartburn. 8. Fatigue: Feeling tired or having a lack of energy is another possible side effect. It's important to consult with your healthcare provider if you experience any of these side effects or if they become severe or persistent. They can provide guidance on whether further action is necessary and if any adjustments to your medication are required.

The active ingredient in Brilinta is ticagrelor. Ticagrelor belongs to a class of medications called antiplatelet drugs. It works by preventing blood platelets from sticking together, which helps to lower the risk of blood clots that can lead to heart attack, stroke, or other cardiovascular issues. In addition to ticagrelor, Brilinta also contains several inactive ingredients that help with the formulation and stability of the medication. However, the specific inactive ingredients may vary depending on the manufacturer or formulation of the medication. It's always best to check the product label or consult with a healthcare professional for the most accurate and up-to-date information on the inactive ingredients in Brilinta.

Brilinta, also known by its generic name ticagrelor, is an antiplatelet medication prescribed to reduce the risk of heart attack, stroke, and other cardiovascular problems in individuals with certain heart conditions. To ensure the effectiveness and safety of Brilinta, proper storage is essential. Here are some key points to consider when handling the medication: 1. Store Brilinta at room temperature: Keep it at a temperature between 68°F and 77°F (20°C and 25°C). Avoid extreme temperature variations, as this can affect the quality of the medication. 2. Protect from moisture: Keep the medication in its original container and store it in a dry place. Moisture can degrade the effectiveness of the medication. 3. Keep away from light: Store Brilinta in a cool, dark place away from direct sunlight or bright artificial light. Exposure to light can also affect the stability of the medication. 4. Store out of reach of children and pets: Ensure that Brilinta is stored in a secure location, out of sight and reach of children or pets who might accidentally ingest it. 5. Follow medication disposal guidelines: If you have any unused or expired Brilinta tablets, consult your pharmacist or healthcare provider on the proper disposal methods. Do not flush them down the toilet or dispose of them in household waste unless specifically instructed to do so. Remember, it is important to always consult with a healthcare professional or pharmacist for specific storage guidelines for Brilinta, as individual situations may vary.